Market Niche Target healthcare institutions and diagnostics labs that require rapid, point-of-need pathogen detection to replace or augment traditional lab-based workflows, highlighting Seraspec as a faster, safer alternative with real-time results.

Growth & Funding Leverage the current revenue range and $9.2M funding to approach investors and strategic partners for co-development, manufacturing scale, and distribution deals with larger medical equipment companies.

Tech Synergy Position the technology stack and cloud/AI capabilities as enablers for scalable, compliant deployments in hospitals and clinics, opening conversations with vendors offering integrated IT and device ecosystems.

Competitive Position Differentiate against larger incumbents by emphasizing portability, real-time detection, reduced specimen handling, and cost savings to smaller to mid-sized healthcare providers seeking efficient infection screening solutions.

Strategic Partnerships Explore collaboration with established diagnostic device players (e.g., B2B distributors, OEMs) and academic medical centers for pilot programs to validate performance, accelerate regulatory clearance, and drive early adoption.